Envista (NYSE:NVST) Price Target Lowered to $21.00 at UBS Group

Envista (NYSE:NVST) had its price target trimmed by UBS Group from $23.00 to $21.00 in a report published on Monday,Benzinga reports. The brokerage currently has a neutral rating on the stock.

NVST has been the topic of several other research reports. JPMorgan Chase & Co. lowered their price target on Envista from $20.00 to $19.00 and set a “neutral” rating on the stock in a report on Thursday, March 6th. Jefferies Financial Group increased their price target on Envista from $20.00 to $22.00 and gave the company a “hold” rating in a report on Thursday, January 23rd. Needham & Company LLC reissued a “hold” rating on shares of Envista in a research report on Thursday, March 6th. Morgan Stanley reduced their price objective on Envista from $20.00 to $19.00 and set an “equal weight” rating for the company in a research report on Thursday, March 6th. Finally, Wells Fargo & Company increased their price objective on Envista from $20.00 to $21.00 and gave the company an “equal weight” rating in a research report on Thursday, February 6th. Two analysts have rated the stock with a sell rating, ten have issued a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, Envista has an average rating of “Hold” and a consensus price target of $20.18.

Envista Price Performance

NVST stock opened at $17.55 on Monday. The company has a current ratio of 2.04, a quick ratio of 1.76 and a debt-to-equity ratio of 0.44. Envista has a one year low of $15.15 and a one year high of $23.00. The firm has a market capitalization of $3.02 billion, a PE ratio of -2.70, a P/E/G ratio of 1.27 and a beta of 1.33. The firm has a 50-day moving average of $20.19 and a two-hundred day moving average of $19.70.

Envista (NYSE:NVST) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $0.24 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.23 by $0.01. Envista had a negative net margin of 44.56% and a positive return on equity of 3.86%. On average, analysts forecast that Envista will post 1 earnings per share for the current year.

Hedge Funds Weigh In On Envista

Several hedge funds have recently added to or reduced their stakes in the company. Franklin Resources Inc. boosted its holdings in Envista by 72.6% during the fourth quarter. Franklin Resources Inc. now owns 6,854,506 shares of the company’s stock worth $132,223,000 after buying an additional 2,882,844 shares during the last quarter. Iron Triangle Partners LP bought a new position in Envista during the third quarter worth about $43,262,000. Brickwood Asset Management LLP bought a new position in Envista during the fourth quarter worth about $40,037,000. Norges Bank bought a new position in shares of Envista during the 4th quarter valued at about $38,052,000. Finally, Point72 Asset Management L.P. bought a new position in shares of Envista during the 3rd quarter valued at about $37,559,000.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.